Loading provider…
Loading provider…
Hematology & Oncology Physician in Cleveland, OH
NPI: 1457319717Primary Practice Location
CLEVELAND CLINIC
9500 Euclid Ave, Cleveland, OH
Primary Employer
Cleveland Clinic
clevelandclinic.org
HQ Phone
Get M.D. Hetty's Phone Numberphone_androidMobile
Get M.D. Hetty's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
OH State Medical License
2013 - 2027
MD State Medical License
2001 - 2026
Johns Hopkins University
2004 - 2008
2004 - 2008
Fellowship • Hematology and Medical Oncology
2001 - 2005
Residency • Internal Medicine
1998 - 2001
Johns Hopkins Carey Business School
Business
2004 - 2006
UMass Chan Medical School
umassmed.edu
Medical School
Until 1998
Brandeis University
B.A. • Biology & Neuroscience
1989 - 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 44 | 140 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 20 | 111 |
| 3 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 16 | 28 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 14 | 18 |
Current and emerging strategies for management of myelodysplastic syndromes.
Authors: Saygin, Caner, Carraway, Hetty E
Journal: Blood Rev
Publication Date: 2020-12-27
Lead Sponsor: Mikkael Sekeres, MD
Collaborators: Bristol-Myers Squibb, Celgene
Intervention / Treatment: DRUG: Lenalidomide, DRUG: Luspatercept
Lead Sponsor: Syros Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Azacitidine, DRUG: Tamibarotene
Lead Sponsor: Immune-Onc Therapeutics
Collaborators: California Institute for Regenerative Medicine (CIRM)
Intervention / Treatment: BIOLOGICAL: IO-202, BIOLOGICAL: IO-202 and Azacitidine, BIOLOGICAL: IO-202 and Azacitidine + Venetoclax